US Stock MarketDetailed Quotes

Neumora Therapeutics (NMRA)

Watchlist
  • 2.300
  • -0.010-0.43%
Close May 5 16:00 ET
420.18MMarket Cap-1.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neumora Therapeutics (NMRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.47%241.16M
-7.06%58.48M
-24.72%57.7M
-15.33%54.04M
18.08%70.94M
4.51%263.46M
-44.81%62.92M
34.79%76.65M
51.73%63.82M
53.38%60.07M
Selling and administrative expenses
-3.91%60.09M
-18.81%13.81M
-23.95%12.18M
0.80%15.32M
31.21%18.79M
37.52%62.54M
51.39%17.01M
4.93%16.02M
63.50%15.19M
47.86%14.32M
-General and administrative expense
-3.91%60.09M
-18.81%13.81M
-23.95%12.18M
0.80%15.32M
31.21%18.79M
37.52%62.54M
51.39%17.01M
4.93%16.02M
63.50%15.19M
47.86%14.32M
Research and development costs
-9.89%181.07M
-2.71%44.67M
-24.92%45.52M
-20.37%38.72M
13.97%52.15M
-2.76%200.93M
-55.32%45.91M
45.74%60.63M
48.40%48.63M
55.19%45.76M
Operating profit
8.47%-241.16M
7.06%-58.48M
24.72%-57.7M
15.33%-54.04M
-18.08%-70.94M
-4.51%-263.46M
44.81%-62.92M
-34.79%-76.65M
-51.73%-63.82M
-53.38%-60.07M
Net non-operating interest income expense
-74.29%5.13M
-117.15%-701K
-77.71%938K
-65.59%1.81M
-51.70%3.07M
20.00%19.93M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
78.34%6.37M
Non-operating interest income
-58.14%8.34M
-67.34%1.34M
-59.97%1.69M
-65.59%1.81M
-51.70%3.07M
20.00%19.93M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
78.34%6.37M
Non-operating interest expense
--3.22M
--2.04M
--747K
----
----
----
----
--0
----
----
Other net income (expense)
-883.33%-767K
-1,893.33%-269K
112.28%7K
-1,900.00%-480K
-108.33%-25K
54.12%-78K
114.42%15K
-5,600.00%-57K
38.46%-24K
53.85%-12K
Other non- operating income (expenses)
-883.33%-767K
-1,893.33%-269K
112.28%7K
-1,900.00%-480K
-108.33%-25K
54.12%-78K
114.42%15K
-5,600.00%-57K
38.46%-24K
53.85%-12K
Income before tax
2.80%-236.8M
-1.07%-59.45M
21.71%-56.76M
10.02%-52.71M
-26.37%-67.89M
-3.37%-243.61M
45.77%-58.82M
-36.71%-72.49M
-51.97%-58.58M
-50.80%-53.72M
Income tax
-26.97%130K
0
0
-80.00%25K
105K
-33.58%178K
0
53K
125K
0
Net income
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
Net income continuous Operations
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
Minority interest income
Net income attributable to the parent company
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
Basic earnings per share
5.23%-1.45
5.41%-0.35
22.22%-0.35
10.81%-0.33
-23.53%-0.42
57.85%-1.53
45.95%-0.37
60.53%-0.45
-45.87%-0.37
-45.02%-0.34
Diluted earnings per share
5.23%-1.45
5.41%-0.35
22.22%-0.35
10.81%-0.33
-23.53%-0.42
57.85%-1.53
45.95%-0.37
60.53%-0.45
-45.87%-0.37
-45.02%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.47%241.16M-7.06%58.48M-24.72%57.7M-15.33%54.04M18.08%70.94M4.51%263.46M-44.81%62.92M34.79%76.65M51.73%63.82M53.38%60.07M
Selling and administrative expenses -3.91%60.09M-18.81%13.81M-23.95%12.18M0.80%15.32M31.21%18.79M37.52%62.54M51.39%17.01M4.93%16.02M63.50%15.19M47.86%14.32M
-General and administrative expense -3.91%60.09M-18.81%13.81M-23.95%12.18M0.80%15.32M31.21%18.79M37.52%62.54M51.39%17.01M4.93%16.02M63.50%15.19M47.86%14.32M
Research and development costs -9.89%181.07M-2.71%44.67M-24.92%45.52M-20.37%38.72M13.97%52.15M-2.76%200.93M-55.32%45.91M45.74%60.63M48.40%48.63M55.19%45.76M
Operating profit 8.47%-241.16M7.06%-58.48M24.72%-57.7M15.33%-54.04M-18.08%-70.94M-4.51%-263.46M44.81%-62.92M-34.79%-76.65M-51.73%-63.82M-53.38%-60.07M
Net non-operating interest income expense -74.29%5.13M-117.15%-701K-77.71%938K-65.59%1.81M-51.70%3.07M20.00%19.93M-27.59%4.09M9.67%4.21M48.15%5.27M78.34%6.37M
Non-operating interest income -58.14%8.34M-67.34%1.34M-59.97%1.69M-65.59%1.81M-51.70%3.07M20.00%19.93M-27.59%4.09M9.67%4.21M48.15%5.27M78.34%6.37M
Non-operating interest expense --3.22M--2.04M--747K------------------0--------
Other net income (expense) -883.33%-767K-1,893.33%-269K112.28%7K-1,900.00%-480K-108.33%-25K54.12%-78K114.42%15K-5,600.00%-57K38.46%-24K53.85%-12K
Other non- operating income (expenses) -883.33%-767K-1,893.33%-269K112.28%7K-1,900.00%-480K-108.33%-25K54.12%-78K114.42%15K-5,600.00%-57K38.46%-24K53.85%-12K
Income before tax 2.80%-236.8M-1.07%-59.45M21.71%-56.76M10.02%-52.71M-26.37%-67.89M-3.37%-243.61M45.77%-58.82M-36.71%-72.49M-51.97%-58.58M-50.80%-53.72M
Income tax -26.97%130K00-80.00%25K105K-33.58%178K053K125K0
Net income 2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M
Net income continuous Operations 2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M
Minority interest income
Net income attributable to the parent company 2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M
Basic earnings per share 5.23%-1.455.41%-0.3522.22%-0.3510.81%-0.33-23.53%-0.4257.85%-1.5345.95%-0.3760.53%-0.45-45.87%-0.37-45.02%-0.34
Diluted earnings per share 5.23%-1.455.41%-0.3522.22%-0.3510.81%-0.33-23.53%-0.4257.85%-1.5345.95%-0.3760.53%-0.45-45.87%-0.37-45.02%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.56%
Sample Name
Sample Code
 +14.20%
Sample Name
Sample Code
 +14.18%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+10.58%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.71%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +21.01%
Sample Name
Sample Code
 +20.15%
Sample Name
Sample Code
 +14.82%
4
ASE Technology
ASX
+11.17%
5
Luckin Coffee
LKNCY
+10.14%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report from AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has b Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -